ID28810A - Senyawa-senyawa amida-omega asam n-arilsulfonilamino - Google Patents

Senyawa-senyawa amida-omega asam n-arilsulfonilamino

Info

Publication number
ID28810A
ID28810A IDW00200100995A ID20010995A ID28810A ID 28810 A ID28810 A ID 28810A ID W00200100995 A IDW00200100995 A ID W00200100995A ID 20010995 A ID20010995 A ID 20010995A ID 28810 A ID28810 A ID 28810A
Authority
ID
Indonesia
Prior art keywords
arilsulfonilamino
amida
compounds
omega acid
omega
Prior art date
Application number
IDW00200100995A
Other languages
English (en)
Inventor
Wilfried Schwab
Werner Thorwart
Manferd Schudok
Bukhard Haase
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of ID28810A publication Critical patent/ID28810A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IDW00200100995A 1998-11-06 1999-10-21 Senyawa-senyawa amida-omega asam n-arilsulfonilamino ID28810A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19851184A DE19851184A1 (de) 1998-11-06 1998-11-06 N-Arylsulfonyl-aminosäure-omega-amide

Publications (1)

Publication Number Publication Date
ID28810A true ID28810A (id) 2001-07-05

Family

ID=7886902

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200100995A ID28810A (id) 1998-11-06 1999-10-21 Senyawa-senyawa amida-omega asam n-arilsulfonilamino

Country Status (23)

Country Link
US (2) US6201130B1 (id)
EP (1) EP1124797B1 (id)
JP (1) JP4348014B2 (id)
KR (1) KR100655632B1 (id)
CN (1) CN1206213C (id)
AR (1) AR021086A1 (id)
AT (1) ATE260889T1 (id)
AU (1) AU757602B2 (id)
BR (1) BR9915729A (id)
CA (1) CA2350031C (id)
CZ (1) CZ302291B6 (id)
DE (2) DE19851184A1 (id)
DK (1) DK1124797T3 (id)
ES (1) ES2213405T3 (id)
HK (1) HK1041686B (id)
HU (1) HUP0104122A3 (id)
ID (1) ID28810A (id)
PL (1) PL198827B1 (id)
PT (1) PT1124797E (id)
RU (1) RU2228330C2 (id)
TR (1) TR200101245T2 (id)
WO (1) WO2000027808A1 (id)
ZA (1) ZA200103485B (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
US7071223B1 (en) * 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
CA2521364A1 (en) * 2003-04-15 2004-10-28 Warner-Lambert Company Llc [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
MXPA05012086A (es) * 2003-05-12 2006-02-22 Pfizer Prod Inc Inhibidores de benzamida del receptor p2x7.
AU2005258924A1 (en) * 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3H-`1,2,4!-triazin-2-YK!benzamide derivatives with P2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid
JP2008504360A (ja) * 2004-06-29 2008-02-14 ファイザー・プロダクツ・インク ヒドロキシル保護された前駆体を脱保護することによる５−［４−（２−ヒドロキシ−プロピル）−３，５−ジオキソ−４，５−ジヒドロ−３ｈ−１，２，４−トリアジン−２−イル］−ベンズアミド誘導体の製造方法
JP2008504363A (ja) * 2004-06-29 2008-02-14 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Ｐ２ｘ７受容体のベンズアミド阻害剤を利用する併用療法
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
JP5181118B2 (ja) * 2005-07-11 2013-04-10 ワイス・エルエルシー グルタミン酸アグリカナーゼ阻害剤
KR20080058436A (ko) 2005-10-13 2008-06-25 와이어쓰 글루탐산 유도체의 제조 방법
ES2533065T3 (es) 2010-07-09 2015-04-07 Pfizer Limited Bencenosulfonamidas útiles como inhibidores de los canales de sodio
JP6360500B2 (ja) * 2013-02-06 2018-07-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 骨関節炎の処置のためのアグリカナーゼ阻害剤としての置換カルボン酸誘導体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1063026A1 (ru) * 1982-05-19 1990-12-07 Институт биохимии АН ЛитССР N @ -Бензолсульфонильные производные трес-DL-фенилсерина, обладающие противовоспалительной активностью
JP2764262B2 (ja) 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
TW201303B (id) 1990-07-05 1993-03-01 Hoffmann La Roche
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
JPH10501806A (ja) 1994-06-22 1998-02-17 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 金属タンパク質分解酵素阻害剤
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
JP2000500161A (ja) * 1995-06-28 2000-01-11 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー フッ素重合体のナノ複合体
KR980009238A (ko) 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
EE03965B1 (et) * 1996-05-17 2003-02-17 Warner-Lambert Company Maatriksi metalloproteinaasi bifenüülsulfoonamiidinhibiitorid
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren

Also Published As

Publication number Publication date
CN1332724A (zh) 2002-01-23
AR021086A1 (es) 2002-06-12
PL198827B1 (pl) 2008-07-31
KR20010080385A (ko) 2001-08-22
TR200101245T2 (tr) 2001-10-22
KR100655632B1 (ko) 2006-12-12
CA2350031C (en) 2010-01-26
DE19851184A1 (de) 2000-05-11
CN1206213C (zh) 2005-06-15
BR9915729A (pt) 2001-10-23
ATE260889T1 (de) 2004-03-15
US6335333B1 (en) 2002-01-01
CA2350031A1 (en) 2000-05-18
DE59908769D1 (de) 2004-04-08
ES2213405T3 (es) 2004-08-16
RU2228330C2 (ru) 2004-05-10
PT1124797E (pt) 2004-07-30
JP4348014B2 (ja) 2009-10-21
HK1041686B (zh) 2005-09-23
US6201130B1 (en) 2001-03-13
HUP0104122A3 (en) 2002-04-29
JP2002529447A (ja) 2002-09-10
HK1041686A1 (en) 2002-07-19
HUP0104122A2 (hu) 2002-03-28
PL347574A1 (en) 2002-04-08
EP1124797B1 (de) 2004-03-03
DK1124797T3 (da) 2004-07-05
WO2000027808A1 (de) 2000-05-18
CZ20011506A3 (cs) 2001-08-15
CZ302291B6 (cs) 2011-02-09
AU1153000A (en) 2000-05-29
AU757602B2 (en) 2003-02-27
EP1124797A1 (de) 2001-08-22
ZA200103485B (en) 2001-12-04

Similar Documents

Publication Publication Date Title
ID26222A (id) Hidroksamida asam(4-arilsulfonilamino)-tetrahidropiran-4-karboksilat
ID28833A (id) Turunan asam 3-aril-2-hidroksipropionat
ID20809A (id) Asam diaminokarboksilat tersubstitusi
ATE269861T1 (de) Substituierte indolalkansäure
ID28699A (id) Turunan-turunan asam oksiiminoalkanoat
ID22095A (id) Asam aril-akrilat ester
ID20807A (id) Asam sulfonilaminokarboksilat
ID26978A (id) Turunan-turunan asam aminometilkarboksilat
LTC1124961I2 (lt) Trombopoetino junginiai
ID24626A (id) Turunan-turunan asam hidroksamat sebagai penghambat metaloprotease matriks (mmp)
ATE229954T1 (de) Betacarbolinverbindungen
ID23668A (id) Turunan asam ariloksiarilsulfonilamino hidroksamat
ID28266A (id) Senyawa-senyawa amidin
ID24376A (id) Turunan-turunan asam amidokarboksilat
ID28164A (id) Turunan iii asam 3-aril-2-hidroksipropionat baru
NO20011745L (no) Forbindelser
ID27390A (id) Pembuatan asam akrilat
NO20005006L (no) Kalsilytiske forbindelser
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
ID28810A (id) Senyawa-senyawa amida-omega asam n-arilsulfonilamino
NO20006662D0 (no) Fluorfenylresin-forbindelser
NO991561L (no) 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
ID27729A (id) Komposisi-komposisi anti-enzim yang mengandung asam etilendiamin disuksinat
ID21355A (id) Pembuatan asam adipat
ATE250572T1 (de) Aromatische sulphonyl-alpha-hydroxy- hydroxamsäureverbindungen